Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Solana Beach, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Evoke Pharma Inc has filed 665 SEC EDGAR filings since 11 Jun 2007

SEC filing history

Showing 501-525 of 662 matching filings.

Per page
25
Current page
21
4

PRIMARY DOCUMENT

Filing date
21 Apr 2016
Reporting date
19 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Apr 2016
Reporting date
19 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
15 Apr 2016
Reporting date
15 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-200176

424B5

Filing date
15 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Apr 2016
Reporting date
11 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Apr 2016
Reporting date
11 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Apr 2016
Reporting date
06 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36075

DEFA14A

Filing date
15 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36075

DEF 14A

Filing date
15 Mar 2016
Reporting date
27 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
10 Mar 2016
Reporting date
10 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Mar 2016
Reporting date
01 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
01 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2016
Reporting date
05 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2016
Reporting date
05 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Feb 2016
Reporting date
05 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jan 2016
Reporting date
28 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jan 2016
Reporting date
28 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jan 2016
Reporting date
28 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87872

AMENDMENT 1 TO SCHEDULE 13G FOR EVOKE PHARMA BY DOMAIN PARTNERS VII, L.P.

Filing date
19 Jan 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
18 Dec 2015
Reporting date
01 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36075

8-K

Filing date
12 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .